BioTurnKey

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

bioturnkey.com

Stage

Seed VC | Alive

About BioTurnKey

Developer of products for clinical testing, therapies, devices, and other life science products. The company, a joint venture between life science contract manufacturer Incell and Wisetree Invest, aims to accelerate the development and manufacturing of regenerative and personalized medicine products for clinical testing, therapies, devices, and other life science products and services, using Incell’s manufacturing technology, and to create spin-out companies of them.

BioTurnKey Headquarter Location

Novalis Science Park Rue de la Science 8

Aye, 6900,

Belgium

32 4 861 358 57

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.